Chapter 21. Interstitial Lung Disease in the Elderly

  1. Stephen Jackson Professor of Geriatric Medicine2,
  2. Paul Jansen3 and
  3. Arduino Mangoni4
  1. Jeffrey Bowden

Published Online: 2 APR 2009

DOI: 10.1002/9780470017975.ch21

Prescribing for Elderly Patients

Prescribing for Elderly Patients

How to Cite

Bowden, J. (2009) Interstitial Lung Disease in the Elderly, in Prescribing for Elderly Patients (eds S. Jackson, P. Jansen and A. Mangoni), John Wiley & Sons, Ltd, Chichester, UK. doi: 10.1002/9780470017975.ch21

Editor Information

  1. 2

    Department of Clinical Gerontology, King's College Hospital, London, UK

  2. 3

    Department of Geriatric Medicine, University Medical Centre Utrecht, Utrecht, The Netherlands

  3. 4

    Department of Clinical Pharmacology, Flinders University, Flinders Medical Centre, Adelaide, Australia

Author Information

  1. Department of Medicine, Flinders Medical Centre, Adelaide, Australia

Publication History

  1. Published Online: 2 APR 2009
  2. Published Print: 27 MAY 2009

ISBN Information

Print ISBN: 9780470024287

Online ISBN: 9780470017975



  • treatment of interstitial lung disease (ILD);
  • aetiology of interstitial lung disease;
  • interstitial lung disease in elderly;
  • assessing response to therapy;
  • mechanism of action—azathioprine, a purine analog;
  • methotrexate (MTX) - antimetabolite with immunosuppressive and anti-inflammatory properties;
  • sarcoidosis - multisystem granulomatous disorder of unknown aetiology manifested by non-caseating infiltration;
  • bronchiolitis obliterans organizing pneumonia (BOOP);
  • hypersensitivity pneumonitis


This chapter contains sections titled:

  • Introduction

  • Presentation of interstitial lung disease

  • Particular problems in the elderly

  • General comments with regard to therapy

  • Assessing the response to therapy

  • Drugs used in ILD

  • Treatment for specific forms of lung disease

  • Key points

  • Links

  • References